Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

Atorvastatin + Telmisartan (AtorTel)

Source date not recordedAnalyse record ↗
Modality
small molecule
Kind
rate-of-aging
Tested by ITP
yes
ITP year first tested
2022
ITP median % ↑ (♂, best cohort)
4.20
ITP median % ↑ (♀, best cohort)
-3.80
ITP P90 % ↑ (♂, best cohort)
-3.40
ITP P90 % ↑ (♀, best cohort)
-2.90
ITP sex effect
neither
ITP dose (ppm)
Ator: 120 ppm; Tel:30 ppm
ITP age at start (mo)
7 mo
ITP replicated
no
ITP result status
Published (full stats)

ITP cohort detail (1)

YearCohortDose♂ med♀ med♂ P90♀ P90Citation
2022C2022Ator: 120 ppm; Tel:30 ppm4.2%-3.8%-3.4%-2.9%↗ paper